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1554Objectives:Our objective was to determine the contribution of endobronchial ultrasound in the diagnostic yields
of acid-fast bacillus smear, nucleic acid amplification tests, and culture in bronchoalveolar lavage fluid for pul-
monary tuberculosis.
Methods: During a 1-year interval, 99 patients who had initial sputum-negative acid-fast bacillus smears or no
sputum but were later proven to have a positive culture forMycobacterium tuberculosis in their sputum or bron-
choalveolar lavage fluid were retrospectively studied. Among them, 56 patients underwent bronchoscopy with
endobronchial ultrasound (EBUS group) and 43 patients received conventional bronchoscopy for bronchoalveo-
lar lavage (non-EBUS group).
Results: The diagnostic yields of the nucleic acid amplification tests (89.3%, 50/56; P ¼ .006), acid-fast ba-
cillus smear (30.4%, 17/56; P ¼ .013), and M tuberculosis culture in bronchoalveolar lavage fluid (67.9%,
38/56; P ¼ .041) were significantly higher in the EBUS group of patients. The results of those who underwent
conventional bronchoscopy were 65.1% (28/43), 9.3% (4/43), and 46.5% (20/43), respectively. Combining
bronchoalveolar lavage fluid smear and nucleic acid amplification tests, we made a rapid diagnosis of pulmo-
nary tuberculosis in 51 (91.1%) of the 56 EBUS patients and 29 (67.4%; P ¼ .004) of the 43 non-EBUS
patients.
Conclusions: The introduction of endobronchial ultrasound increases the diagnostic yield of the nucleic acid
amplification tests, acid-fast bacillus smear, and M tuberculosis culture from bronchioalveolar lavage fluid in
patients with pulmonary tuberculosis who have negative sputum smear or no sputum production. (J Thorac
Cardiovasc Surg 2010;139:1554-60)The definitive diagnosis of active pulmonary tuberculosis
(TB) usually requires the isolation ofMycobacterium tuber-
culosis from respiratory secretions. It may take up to 6 weeks
to identify M tuberculosis from cultured specimens,1 al-
though the detection time may be shortened when automated
and semiautomated liquid culture systems are used.2,3
Thus, it is common practice to commence early expectant
treatment for pulmonary TB on the basis of clinical
evidence even before culture confirmation. Among this
clinical evidence, sputum examination is the most useful
method for diagnosing active pulmonary TB.4 However, be-
tween 25% and 60% of patients with pulmonary TB have
negative sputum smears or no spontaneous sputum produc-
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The Journal of Thoracic and Cardiovascular Surthese patients. This error may incur delays in the treatment
of pulmonary TB until the return of positive culture results.
As a result, delays in diagnosis and treatment have been rec-
ognized as an important cause of death due to pulmonary
TB.6 The utility of rapid diagnostic tests in the early detection
of smear-negative TB is, therefore, an important clinical con-
sideration. It is also of considerable interest to public health.
Nucleic acid amplification tests (NAATs) are rapid, sensi-
tive, and specific for the detection ofM tuberculosis complex
DNA or RNA in respiratory specimens.7 NAATs have
higher sensitivity than acid-fast or fluorochrome smears in
detecting culture-positive samples because their detection
threshold is as low as 1 organism per 100 mL of sample.
They have a sensitivity and specificity greater than 95% in
smear-positive specimens.8 However, in smear-negative
samples the sensitivity of polymerase chain reaction (PCR)
is between 40% and 77% but the specificity remains
high.9 The wide range of sensitivity may be explained by
the use of different samples such as bronchoalveolar lavage
fluid (BALF) versus sputum. In fact, a recent study has
disclosed that a combined use of BALF smears andM tuber-
culosis NAATs has a good diagnostic yield in patients
with sputum smear–negative TB or those without sputum
production.10
Bronchoscopy with an acid-fast bacillus (AFB) smear and
a culture forMtuberculosis ofBALFhave been introduced togery c June 2010
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FIGURE 1. Analysis of patients with suspected pulmonary tuberculosis.
BAL, Bronchoalveolar lavage; BALF, bronchoalveolar lavage fluid; BAL
with EBUS, endobronchial ultrasound; BAL without EBUS, conventional
bronchoscopy; PCR, polymerase chain reaction.
Abbreviations and Acronyms
AFB ¼ acid-fast bacillus
AMTD ¼ Amplified Mycobacterium Tuberculosis
Direct
BAL ¼ bronchoalveolar lavage
BALF ¼ bronchoalveolar lavage fluid
CI ¼ confidence intervals
CT ¼ computed tomography
EBUS ¼ endobronchial ultrasonography
NAATs ¼ nucleic acid amplification tests
OR ¼ odds ratios
PCR ¼ polymerase chain reaction
TB ¼ tuberculosis
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Mobtain a bacteriologic diagnosis of TB in smear-negative
patients or patients unable to expectorate.11 Endobronchial
ultrasonography (EBUS), a newly introduced technique,
has also been applied to assess peripheral lung lesions.12
Compared with conventional bronchoscopy, EBUS offers
the benefits of visualizing the parabronchial structure, con-
firming the precise location of peripheral lung lesions, and
therefore improving the diagnostic yield of lung cancer.13,14
However, few studies have investigated the role of EBUS in
the diagnosis of benign lung lesion. Our recent study has
demonstrated that the addition of EBUS to a diagnostic
bronchoscopy increases the incidence for proving the
presence of TB in a population of patients with negative
AFB smear or no sputum production.15 The study analyzed
all subjects with pulmonary TB. Therefore, the sensitivity,
specificity, and positive and negative predictive values could
not be determined. In addition, the role of bronchoscopywith
the aid of EBUS in the positive yield of NAATs for pulmo-
nary TB in sputum-negative patients is still undetermined.
This study was designed to compare the diagnostic yields
of AFB smear, NAATs, and M tuberculosis culture in
BALF for pulmonary TB by bronchoscopy, with or without
EBUS, in patients with a negative sputum smear or without
sputum production. The contributions of EBUS-guided
procedures on the early diagnosis of pulmonary TB were
also determined.
PATIENTS AND METHODS
Study Subjects
This study retrospectively analyzed patients who underwent bronchos-
copy at Chang Gung Memorial Hospital, a university-affiliated, 3300-bed
hospital in Taiwan. With the capability of performing Amplified Mycobac-
terium Tuberculosis Direct (AMTD) test since 2006, the institutional guide-
line recommended that patients with symptoms or chest radiographs
suggestive of pulmonary TB may receive bronchoalveolar lavage (BAL)
for AFB smear,M tuberculosis culture, and AMTD test. Before introduction
of the guideline, patients with suspected pulmonary TB received bronchos-
copy for BAL and transbronchial lung biopsy.15 In contrast, no patients re-
ceived biopsy in the present study. The inclusion criteria were symptoms orThe Journal of Thoracic and Carchest radiographs suggestive of pulmonary TB in patients who received
BAL because of their lack of spontaneous sputum or a negative AFB smear
in 3 consecutive daily sputum specimens. The exclusion criteria were failure
to receive a complete BAL procedure or sputum smears that were positive
for AFB. From June 2006 to July 2007, a total of 347 patients with symp-
toms or chest radiographs suggestive of pulmonary TB were referred to our
bronchoscopic center for BAL because of their lack of spontaneous sputum
or a negative AFB smear in 3 consecutive daily sputum specimens
(Figure 1). There are 2 bronchoscopy rooms in the bronchoscopic center
but only 1 of them is equipped with the EBUS system. Patients referred
to the bronchoscopic center received bronchoscopy with or without
EBUS depending on the availability of the room equipped with the EBUS
system. Among the 347 patients, 99 had a positive culture forM tuberculo-
sis in sputum or BALF, whereas the absence of M tuberculosis in both
BALF and sputum was found in the other 248 patients. Patients who re-
ceived bronchoscopic examination with EBUS guidance were defined as
the EBUS group. The other patients underwent bronchoscopic examinations
during the time period when EBUS was not available. They received bron-
choscopic examination without EBUS guidance and were designated as the
non-EBUS group. The diagnostic yields of the BALF AFB smear, AMTD
test, and culture for M tuberculosis were compared between both groups.
None of them was infected with human immunodeficiency virus. Informed
consent to undergo bronchoscopy was obtained from all the subjects, and
this study was approved by the hospital internal review board. Patients’
baselines included age, gender, location and size of lesion, and radiologic
appearance. Their underlying medical history was also collected, including
diabetes mellitus, hypertension, history of malignancy, chronic airway
obstructive disease, and previous TB infection.
Procedure and Equipment of Bronchoscopy
The bronchoscopic examinations were performed by experienced bron-
choscopists who had performed more than 200 bronchoscopic procedures
each year. To ensure the quality of EBUS in the study, we retrieved the
EBUS group after each of the bronchoscopists had performed more than
50 EBUS procedures. The probable location of the lesion was determined
initially by traditional posteroanterior chest radiography with and without
chest computed tomography (CT). A flexible fiberoptic bronchoscope
(BF-P240 or BF-40; Olympus, Tokyo, Japan) was then inserted via the nos-
tril after anesthetizing with a local spray of 2% lidocaine (Xylocaine). Indiovascular Surgery c Volume 139, Number 6 1555
TABLE 1. Characteristics of 347 patients undergoing bronchoscopy
Variables No. (%)
Age, y (mean ± SD) 54.9  12.8
Female gender (n,%) 166 (47.8%)
Size of lesion, cm (mean  SD) 3.7  1.9
Lobe distribution of lesions (n,%)
Right upper lobe 145 (41.8%)
Right middle lobe 32 (9.2%)
Right lower lobe 28 (8.1%)
Left upper lobe 128 (36.9%)
Left lower lobe 14 (4.0%)
Benign lesions (n,%) 213 (61.4%)
Tuberculosis 99 (28.5%)
Pneumonia or other infection disease 58 (16.7%)
Fibrosis 41 (11.8%)
Organizing pneumonia 15 (4.3%)
Malignant lesions (n,%) 134 (38.6%)
Non–small cell lung cancer 121 (34.9%)
Small cell lung cancer 13 (3.7%)
Metastatic cancer 10 (2.9%)
SD, Standard deviation.
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Mpatients who received bronchoscopy with EBUS, a 20-MHz radial me-
chanical type ultrasound probe (model UM-S20-S20R; Olympus) and an
ultrasound unit (Endoscopic Ultrasound System; Olympus) were used in
the procedure. To assess lesions in the periphery of the lung, we advanced
the EBUS catheter into the fourth- to sixth-order bronchi. Once the lesion
was located by EBUS, the neighboring bronchiolar orifices were also ex-
amined to ensure the precise location of lesions. Each EBUS image was
evaluated for 3 features including the continuous margin of the lesion,
the presence of an air bronchogram, and heterogeneous echogenicity of
the internal structure.13 The EBUS procedure was performed without
a guide sheath.
Specimen Processing
In the EBUS group, BAL was performed via the bronchiolar orifice
determined by the EBUS image. In the conventional bronchoscopy group,
the location of the lesion was determined by chest radiographs or CT and
BAL was performed as far as the bronchoscope could advance. BAL
was performed by infusion of 6 aliquots of 50 mL normal saline.16 The
return was submitted for the AFB smear, AMTD tests, and culture. Lavaged
specimens were processed by standard methods and stained with fluoro-
chrome.11 The specimens were decontaminated with N-acetyl-L-cysteine-
NaOH (BBL MycoPrep; Becton Dickinson, Cockeysville, Md). Positive
smears were confirmed by Ziehl–Neelsen staining. Specimens were cultured
with BACTEC 12B vials (radiometric BACTEC 460TB system; Becton
Dickinson, Franklin Lakes, NJ) and Lowenstein–Jensen media (Bio-Rad,
Marnesla-Coquette, France). PCR testing for M tuberculosis complex was
performed with the AMTD test kit (Gen-Probe, San Diego, Calif) according
to the instructions of the manufacturer.17 The specimen results were read in
a Leader 450 luminometer (Gen-Probe); a cutoff value of 30,000 relative
light units or more was used for diagnosing positive specimens. Positive
and negative controls were included in every run. The primary diagnosis
of TBwasmade by a positive AFB smear or NAATs in BALF; the definitive
diagnosis was confirmed by the presence ofM tuberculosis cultured in spu-
tum or BALF. The treatment of TB was started if a positive AFB smear or
NAATs in BALF were obtained. For those with a negative AFB smear and
NAATs in BALF, anti-TB treatment was started until the results of positive
M tuberculosis cultured in sputum or BALF were obtained. The time to di-
agnosis and treatment of TBwasmeasured from the patient’s first visit to the
medical center to the diagnosis and treatment of TB.1556 The Journal of Thoracic and Cardiovascular SurStatistical Analysis
Data are expressed as either group percentages (categorical variables) or
mean standard deviation (continuous variables). Data were compared be-
tween patients who received bronchoscopy with versus without EBUS. Cat-
egorical variables were compared by c2 or Fisher’s exact test. Odds ratios
(OR) and their 95% confidence intervals (CI) were used to assess the differ-
ence of diagnostic yields between the 2 groups.We applied the t test to com-
pare continuous variables with normal distribution and the Mann–Whitney
test for continuous variables not distributed normally (P< .05 for all). All
analyses were performed with SPSS software version 10.0 (SPSS, Inc,
Chicago, Ill)RESULTS
Patient Characteristics
A total of 347 patients were analyzed in the study
(Table 1). In 99 patients TB was diagnosed owing to the
presence of M tuberculosis cultured in sputum or BALF.
The group comprised 166 women and 181 men with
a mean age of 54.9  12.8 years. The mean lesion size
was 3.7 1.9 cm. Two hundred thirteen patients had benign
lesions and 134 patients had malignant lesions. The baseline
characteristics of patients with culture-confirmed TB are
summarized in Table 2. There were no significant differ-
ences between groups regarding demographic variables,
size of lesion, percentage of retrieved BALF, chest CT
scan, location of lesion, radiologic appearance, and chronic
coexisting conditions. For the EBUS groups, 51 (91.1%) le-
sions could be localized by EBUS. The presence of air bron-
chograms was observed in 44 (78.6%) patients; lesions with
a complete margin and homogeneous echogenicity were de-
tected in 22 (39.3%) and 40 (71.4%) patients, respectively.
Diabetes mellitus was the most frequent chronic comorbid-
ity in the 2 groups. The overall mean time for procedure
was 11.1  2.3 minutes for the EBUS group and 9.7 
2.3 minutes for the non-EBUS group.Sensitivity, Specificity, and Predictive Values of BAL
for the Diagnosis of Pulmonary TB
Sensitivities, specificities, and predictive values of AFB
smear andNAATs for the diagnosis of culture confirmed pul-
monary TB in BALF are shown in Table 3. The sensitivity of
AFB smear in BALF was 30.4% in the EBUS group and
9.3% in the non-EBUS group. The positive predictive value
was 85% in the EBUS group and 66.7% in the non-EBUS
group. The specificities and negative predictive values
were similar in both groups. The sensitivity of NAATs in
BALF was 89.3% in the EBUS group and 65.1% in the
non-EBUS group. The specificities and positive and negative
predictive values were similar in the 2 groups.The Yield of Sputum and Lavage Specimen for
Culture-Confirmed TB Diagnosis
The diagnostic yields of the NAATs in BALF (89.3%, 50/
56; OR, 4.46; 95%CI, 1.56–12.81;P¼ .006), AFB smear in
BALF (30.4%, 17/56; OR, 4.25; 95% CI, 1.31–13.78;gery c June 2010
TABLE 2. The characteristics of patients with culture-confirmed
pulmonary tuberculosis
Baseline characteristics
Without
EBUS (n ¼ 43)
With EBUS
(n ¼ 56)
P
value
Age, y (mean  SD) 48.4  21.9 53.6  19 .210
Female sex, no. (%) 12 (27.9%) 20 (35.7%) .517
Size of lesion, cm (mean  SD) 3.8  1.9 4.3  1.7 .174
Percentage of retrieved BALF 39.2  22 39.4  19.8 .535
Lesion localized by
EBUS, no. (%)
NA 51 (91.1%) NA
With computed tomography 14 (32.6%) 26 (42.4%) .216
Location of lesion
Right upper lobe 21 (48.8%) 22 (39.3%) .415
Right middle lobe 4 (9.3%) 6 (10.7%) 1.00
Right lower lobe 1 (2.3%) 6 (10.7%) .135
Left upper lobe 17 (39.5%) 20 (35.7%) .834
Left lower lobe 0 (0%) 2 (4.7%) .504
Radiologic appearance
Alveolar consolidation 18 (41.9%) 22 (39.3%) .838
Fibronodular infiltration 16 (37.2%) 20 (35.7%) 1.00
Cavity 6 (14%) 8 (14.4%) 1.00
Multiple nodules or mass 4 (9.3%) 7 (12.5%) .752
With lymphadenopathy 4 (9.3%) 3 (5.4%) .464
Miliary shadowing 2 (4.7%) 1 (1.8%) .578
Lower lung field TB 1 (2.3%) 3 (5.4%) .631
Echoic features by EBUS
Presence of air bronchogram NA 44 (78.6%) NA
Complete margin NA 22 (39.3%) NA
Homogenous echogenicity NA 40 (71.4%) NA
Chronic coexisting
condition, no. (%)
Diabetes mellitus 6 (14%) 8 (14.3%) 1.00
Hypertension 6 (14%) 5 (8.9%) .525
Chronic renal insufficiency 5 (11.6%) 2 (4.7%) .234
Cancer 0 (0%) 2 (4.7%) .504
COPD 5 (11.6%) 4 (7.1%) .496
Previous TB infection 1 (2.3%) 2 (4.7%) 1.00
EBUS, Endobronchial ultrasound; SD, standard deviation; TB, tuberculosis; COPD,
chronic obstructive pulmonary disease; NA, not available.
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MP¼ .013), andM tuberculosis in BALF culture (67.9%, 38/
56; OR, 2.43; 95% CI, 1.07–5.53; P ¼ .041) were signifi-
cantly higher in EBUS patients. Diagnostic yields in those
who underwent conventional bronchoscopy were 65.1%
(28/43), 9.3% (4/43), and 46.5% (20/43), respectively
(Table 4). In contrast, similar incidences of positive sputum
M tuberculosis culture were found in both groups. There was
a higher proportion of patients in the conventional group
whose TB diagnosis was documented only by positive cul-
ture (32.6%, either from BALF or sputum) than among
EBUS patients (8.9%; P ¼ .004) (Figure 1). Combining
BALF smear and NAATs allowed a rapid diagnosis of
pulmonary TB to be made in 51 (91.1%) of the 56 EBUS
patients and 29 (67.4%) of the 43 remaining patients
who received conventional bronchoscopy. With the aid of
EBUS, the overall diagnostic yield for TB by bronchoscopicThe Journal of Thoracic and Carprocedures (smear, NAATs, and culture of BALF) was
higher (92.9%) than that for those who did not undergo
EBUS (74.4%; OR, 4.47; 95% CI, 1.31–15.23;
P ¼ .021). In contrast, pulmonary TB was diagnosed only
by sputum culture of M tuberculosis in 4 (7.1%) of the
56 EBUS patients and 11 (25.6%) of the 43 non-EBUS
patients.
The Effects of CT, Location, and Size of Lesion on
NAATs Yields
The use of EBUS in bronchoscopy had higher diagnostic
yields of NAATs than conventional bronchoscopy in pa-
tients with (22/26, 84.6% vs 7/14, 50%; OR, 5.5; 95%
CI, 1.23–24.52; P ¼ .029) or without (28/30, 93.3% vs
21/29, 72.4%; OR, 5.33; 95% CI, 1.02–27.77; P ¼ .042)
chest CT scan before the bronchoscopic procedures. In pa-
tients in whom the lesion was smaller than 3 cm in size,
bronchoscopy with EBUS (n ¼ 40) had a higher diagnostic
yield of NAATs (36/40, 90% vs 15/23, 65.2%; OR, 4.8;
95% CI, 1.25–18.39; P ¼ .022) in BALF than conventional
bronchoscopy (n¼ 23). Despite the lack of statistical signif-
icance, bronchoscopy with EBUS (n ¼ 16) seemed to have
a higher yield of NAATs (14/16, 87.5% vs 15/23, 65%; OR,
3.8; 95% CI, 0.66–21.56; P ¼ .245) in BALF compared
with conventional bronchoscopy (n ¼ 20) in those in
whom the lesion was larger than 3 cm in size.
The Treatment of Pulmonary TB
The time to diagnosis of TB in EBUS patients (18.6 
18.4 days) was shorter than that in non-EBUS patients
(28.7  24.7 days; P ¼ .022). Similarly, the time to initiate
treatment in patients receiving bronchoscopy with EBUS
(26.0 17.7 days; P¼ .013) was shorter than that in patients
receiving conventional bronchoscopy (36.8 24.6 days). In
our study, most of the patients received bronchoscopy in
the outpatient clinic rather than during hospitalization.
Therefore, the time lag between diagnosis of TB and initia-
tion of treatment may be due to the schedule of the next
clinic visit.
Complications
Pneumothorax occurred in 2 (1.2%) patients of the con-
ventional bronchoscopy group and resolved spontaneously,
but no pneumothorax developed after the EBUS procedure.
No major bleeding with hemodynamic instability developed
during the procedure in either group.
DISCUSSION
This study has demonstrated that the introduction of
EBUS increases the diagnostic yield of the NAATs, AFB
smear, and M tuberculosis culture from BALF in patients
with pulmonary TB who have a negative sputum smear or
no spontaneous sputum production. Combining the BALF
smear and NAATs, bronchoscopy with EBUS allows fordiovascular Surgery c Volume 139, Number 6 1557
TABLE 3. Sensitivity, specificity, and predictive values of BALF smear and AMTD test for the diagnosis of culture confirmed pulmonary TB
Procedure
Final diagnosis (no. positive/tested)
Sensitivity (%) Specificity (%)
Positive predictive
value (%)
Negative predictive
value (%)TB Non-TB
BALF smear
With EBUS 17/56 3/130 30.4 97.7 85 76.5
Without EBUS 4/43 2/118 9.3 98.3 66.7 74.8
BALF AMTD
With EBUS 50/56 5/130 89.3 96.2 90.9 95.4
Without EBUS 28/43 3/118 65.1 97.5 90.3 95.4
BALF, Bronchoalveolar lavage fluid; AMTD, Amplified Mycobacterium Tuberculosis Direct; TB, tuberculosis; EBUS, endobronchial ultrasound.
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Ma higher rate of rapid diagnosis of TB than conventional
bronchoscopy in those patients. In addition, the time to diag-
nosis and time to treatment of TB in EBUS patients was
shorter than that in non-EBUS patients.
The clinical application of EBUS began in the early
1990s.12 EBUSwas documented in improving the diagnostic
yield for lung cancer; the EBUS image pattern might offer
clues for differentiating benign lesions from malignant pe-
ripheral lung lesions.13 Apart from its role in the diagnosis
of lung cancer, our previous study had shown that EBUS in-
creased the diagnostic yield of BAL and transbronchial lung
biopsy in TB patients with negative sputum smear.15 How-
ever, that study analyzed all subjects with pulmonary TB;
therefore, the sensitivity, specificity, and positive and nega-
tive predictive values could not be determined. The present
study recruited patients with symptoms or chest radiographs
suggestive of pulmonary TB. In 99 of the 347 patients, TB
was diagnosed owing to the presence of positiveM tubercu-
losis culture. The present study provided the sensitivity,
specificity, and positive and negative predictive value of
BAL smear and NAATs in the diagnosis of pulmonary TB.
A recent study has shown the good diagnostic yield for pul-
monary TB by NAATs in BALF obtained by conventional
bronchoscopy.10 Our study further disclosed that EBUS in-
creased the sensitivity of NAATs in BALF for the diagnosis
of pulmonary TB in patients with sputum smear–negative
condition or those without sputum production.
The sputum-negative conditions in patients with pulmo-
nary TB have been reported to be the major causes of treat-
ment delay for TB.5 To avoid delay in treatment, physiciansTABLE 4. Comparison of results of AMTD, AFB smears, andM tuberculo
pulmonary TB
With EBUS (n ¼ 56)
Positive BALF AMTD 50 (89.3%)
Positive AFB smear of BALF 17 (30.4%)
Positive BALF M tuberculosis culture 38 (67.9%)
Positive sputum M tuberculosis culture 24 (42.9%)
Positive BALF AMTD and/or AFB smear 51 (91.1%)
Positive BALF smear, AMTD, or culture 52 (92.9%)
AMTD,Amplified Mycobacterium Tuberculosis Direct; AFB, acid-fast bacillus; BALF, bron
ratio; CI, confidence interval.
1558 The Journal of Thoracic and Cardiovascular Surhave been using fiberoptic bronchoscopy for obtaining
lower respiratory tract sections in those patients.18 Once
the lesion is not visible by conventional bronchoscopy,
BAL is performed in a best-guess fashion or with the aid
of a fluoroscope.19 In the lesions that are not visualized by
conventional bronchoscopy, EBUS images allow confirma-
tion of the precise location of lesions by direct visualization.
Therefore, with the aid of EBUS to accurately localize the
lesion, bronchoscopy-guided BAL for AFB smear and
NAATs increased the overall diagnostic yield for pulmonary
TB to more than 90%. Pneumothorax is an unusual compli-
cation of BAL. The development of pneumothorax after
BAL had been reported in patients with obstructive airway
disease.20 Compatible with a previous report, our study
showed that pneumothorax developed after BAL in 2 pa-
tients with chronic obstructive pulmonary disease.
When conventional bronchoscopy is performed, knowl-
edge of the CT appearance may improve the diagnostic yield
of lung cancer by better targeting suspicious lesions. This
applies to both endobronchial diseases visible with the bron-
choscope with transbronchial biopsy specimens and wash-
ings taken from the periphery of the lung.21 However, our
study demonstrated that the higher diagnostic yield of
NAATs in EBUS groups than the non-EBUS group was un-
affected by having a CT scan or not. This discrepancy could
be caused by the difference of disease (TB in our study ver-
sus lung cancer in previous studies) and the different proce-
dures used in these studies (NAATs in BALF in our study
versus transbronchial lung biopsy and washing in previous
studies). In addition, bronchoscopy with EBUS had a highersis cultures in BALF and sputum from patients with culture confirmed
Without EBUS (n ¼ 43) OR 95% CI P value
28 (65.1%) 4.46 1.56–12.81 .006
4 (9.3%) 4.25 1.31–13.78 .013
20 (46.5%) 2.43 1.07–5.53 .041
24 (55.8%) 0.59 0.27–1.32 .228
29 (67.4%) 4.92 1.61–15.07 .004
32 (74.4%) 4.47 1.31–15.23 .021
choalveolar lavage fluid; TB, tuberculosis; EBUS, endobronchial ultrasound;OR, odds
gery c June 2010
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Mdiagnostic yield of NAATs in BALF than conventional
bronchoscopy, especially in lesions less than 3 cm in diam-
eter. In those patients with small-sized lesions, it was diffi-
cult to obtain the diagnosis while pulmonary TB was
suspected. Our results provide the evidence for the useful-
ness of bronchoscopy with EBUS in the diagnosis for TB
among patients with small-sized lesions. Owing to the small
sample size in the subgroup with a lesion size of less than
3 cm, the role of EBUS in the diagnostic yield of NAATs
deserves further investigation.
The value of NAATs in respiratory samples to obtain
a rapid diagnosis of pulmonary TB has been described in
many studies.10,22 A positive NAAT result may be
valuable in the early detection of active TB cases that are
smear-negative.23 One previous study reported a sensitivity
of 53% and a specificity of 93% in comparison with the cul-
ture when NAAT was applied to smear-negative speci-
mens24; this suggests that a potentially significant number
of cases of smear-negative TB could be quickly detected
with the expanded use of NAATs. In a patient with clinically
suspected TB who has a negative AFB smear and a positive
NAAT, therapy can be started sooner and contact investiga-
tion can be initiated.25 By combined use of bronchoscopy
and NAATs, Tueller and associates10 have reported that
NAATs in BALF had a sensitivity of 78% for detection of
pulmonary TB in sputum smear–negative patients or pa-
tients without sputum production. Our results have shown
that the NAATs of BALF offered rapid evidence for TB in-
fection in 89.3% of the patients in the EBUS group, but only
in 65.1% of the patients who received conventional bron-
choscopy. Combining AFB smear and NAATs in BALF
as the rapid evidence for diagnosis, only 8.9% of the patients
in the EBUS group needed to wait until a positive culture as
the only evidence for TB diagnosis. In contrast, 32.6% of
the patients in the conventional group had culture as the
only clue for TB diagnosis. The high diagnostic yield of
EBUS-guided bronchoscopy for early diagnosis of TB in-
fection may therefore avoid a delay in administration of
anti-TB treatment or the need for further invasive procedures
such as CT-guided or surgical biopsy to reach a definite
diagnosis.
Some limitations of this study need to be mentioned. First,
results of BALF smear and NAATs may be false positive;
therefore, M tuberculosis cultures in BALF or sputum are
still required for a definite diagnosis. In addition, the study
only recruited patients with negative AFB smear or no spu-
tum production. Therefore, the results of our study could not
be extended to all the patients with suggestive TB lesions.
In conclusion, sputum AFB smears and M tuberculosis
cultures should be performed first in patients in whom pul-
monary TB is suspected. Once a negative sputum AFB
smear or no spontaneous sputum production occurs, the in-
troduction of EBUS increases the diagnostic yield of the
NAATs, AFB smear, and M tuberculosis culture fromThe Journal of Thoracic and CarBALF. By means of a BALF smear and NAATs, bronchos-
copy with EBUS allows for a higher rate of rapid diagnosis
of TB than conventional bronchoscopy in patients with neg-
ative sputum smear or no spontaneous sputum production.References
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